AI assistant
Sending…
ORACLE CORP — Director's Dealing 2012
Jul 13, 2012
29742_dirs_2012-07-13_5f74d46f-fc4a-4f32-b831-fc375ab45558.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2012-07-11
Reporting Person: Kurian Thomas (EVP-Product Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-07-11 | Common Stock | M | 1072500 | $12.44 | Acquired | 1104054 | Direct |
| 2012-07-11 | Common Stock | M | 603000 | $20.73 | Acquired | 1707054 | Direct |
| 2012-07-11 | Common Stock | S | 1675500 | $29.20 | Disposed | 31554 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-11 | Stock Option | $12.44 | M | 1072500 | Disposed | 2016-02-17 | Common Stock (1072500) | Direct |
| 2012-07-11 | Stock Option | $20.73 | M | 603000 | Disposed | 2018-07-03 | Common Stock (603000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $29.20 to $29.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Option vests 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2